NCT03965845 2022-09-19A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid TumorsCalithera Biosciences, IncPhase 1/2 Completed53 enrolled
NCT01149720 2019-02-12Determination of the Relative Bioavailability of ARQ 197 Tablet Formulation With Capsule C Formulation as a Reference in Subjects With Advanced Solid TumorsDaiichi SankyoPhase 1 Completed24 enrolled